Related Experiment Video

Updated: Jun 2, 2026

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

[Graves' orbitopathy]

A Eckstein1, J Esser

  • 1Orthoptik, Universitäts-Augenklinik Essen. anja.eckstein@uk-essen.de

Klinische Monatsblatter Fur Augenheilkunde
|May 3, 2011
PubMed

Insights

Graves' orbitopathy (GO) is an autoimmune condition affecting the eyes. Early treatment and lifestyle changes like smoking cessation can significantly improve outcomes for patients with this thyroid-related eye disease.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Immunology

Context:

  • Graves' orbitopathy (GO) is a complex autoimmune disease associated with hyperthyroidism.
  • It affects 0.5-2% of the population and involves the eyes, skin, and extremities.
  • TSH receptor stimulating antibodies are key drivers of GO pathogenesis.

Purpose:

  • To outline the pathophysiology, clinical manifestations, and management strategies for Graves' orbitopathy.
  • To highlight the role of inflammatory reactions in orbital fibroblasts.
  • To emphasize the impact of smoking and the benefits of euthyroidism.

Summary:

  • GO presents with soft tissue inflammation, proptosis, impaired ocular motility, and lid retraction.
  • Treatment includes anti-inflammatory therapies (steroids, irradiation) for active stages and surgery for inactive or sight-threatening conditions.
  • Selenium administration and a watchful approach are suitable for mild GO.

Impact:

  • Understanding GO's mechanisms guides therapeutic decisions, from anti-inflammatory treatments to surgical interventions.
  • Smoking cessation is crucial for improving GO severity and treatment efficacy.
  • Restoring euthyroidism positively impacts GO in approximately 60% of patients, underscoring the systemic nature of the disease.

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...